Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replication in Prokaryotes02:35

Replication in Prokaryotes

Overview
Replication in Prokaryotes02:35

Replication in Prokaryotes

Overview
Replication in Prokaryotes01:32

Replication in Prokaryotes

DNA replication has three main steps: initiation, elongation, and termination. Replication in prokaryotes begins when initiator proteins bind to the single origin of replication (ori) on the cell's circular chromosome. Replication then proceeds around the entire circle of the chromosome in each direction from the two replication forks, resulting in two DNA molecules.
Many Proteins Work Together to Replicate the Chromosome
Replication is coordinated and carried out by a host of specialized...
Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo assay for organ-specific cancer cell invasion.

Journal of biological engineering·2026
Same author

Advancing and integrating climate and health policy in the United Kingdom: Insights from national policy actors.

The journal of climate change and health·2026
Same author

Perceived eye care risk and safety issues identified by optometrists in Scotland: a focus group study.

BMJ open quality·2026
Same author

Student Progress Dashboard Versus Legacy Academic Monitoring for Medical Student Support: A Consolidated Framework for Implementation Research-Guided Evaluation.

Cureus·2026
Same author

Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.

Cells·2026
Same author

Retrospective Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Alopecia Areata in a Single Dermatological Department.

Journal of clinical medicine·2026

Related Experiment Video

Updated: May 14, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Cellular aspects of prion replication in vitro.

Andrea Grassmann1, Hanna Wolf, Julia Hofmann

  • 1German Center for Neurodegenerative Diseases, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany. andrea.grassmann@dzne.de

Viruses
|January 24, 2013
PubMed
Summary

Prion diseases, fatal neurodegenerative disorders, stem from misfolded prion protein (PrP) aggregates. Cell culture models advance understanding of prion entry and propagation, crucial for developing therapeutic targets.

More Related Videos

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
11:41

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Related Experiment Videos

Last Updated: May 14, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
11:41

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Area of Science:

  • Neurodegenerative Diseases
  • Prion Biology
  • Cellular Trafficking

Background:

  • Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative conditions in mammals.
  • These diseases are caused by misfolded prion protein (PrP) aggregates that self-propagate.

Purpose of the Study:

  • To review the cell biology and propagation of prions using cell culture models.
  • To discuss recent findings on PrP trafficking, synthesis sites, and co-factors in prion entry and propagation.

Main Methods:

  • Summary of knowledge from cell culture experiments on prion entry, propagation, and dissemination.
  • Discussion of recent research on cellular and pathological PrP trafficking.

Main Results:

  • Cell culture models have significantly improved understanding of TSE agent behavior.
  • The precise mechanisms of prion infection and strain effects remain incompletely understood.

Conclusions:

  • Understanding prion cell biology is essential for identifying drug targets for TSE intervention.
  • Further research is needed to elucidate the enigmatic mechanisms of prion infection and strain diversity.